Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one ...

By now, everyone should have access to the second quarter fiscal year 2025 earnings release, which went out today at ...

The recent dramatic US intervention in Venezuela’s political and energy landscape has triggered seismic debates on global ...

Investing.com -- Oculis Holding AG (NASDAQ:OCS) stock surged 9% on Tuesday after the FDA granted breakthrough therapy designation to its neuroprotective candidate Privosegtor for the treatment of ...

S&P expects the take-private deal to result in adjusted leverage of approximately 8.4x in fiscal 2026, a significant increase from just 0.3x in fiscal 2025. The transaction reflects a shift from ...